Acadian Asset Management’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.18M Buy
336,998
+3,883
+1% +$37.1K ﹤0.01% 931
2026
Q1
$3.04M Buy
333,115
+276,775
+491% +$2.32M ﹤0.01% 836
2025
Q4
$416K Buy
+56,340
New +$405K ﹤0.01% 1358
2025
Q3
– Sell
-134,628
Closed -$890K – 1837
2025
Q2
$890K Buy
134,628
+5,061
+4% +$35.9K ﹤0.01% 1001
2025
Q1
$1.18M Sell
129,567
-11,719
-8% -$117K ﹤0.01% 890
2024
Q4
$1.48M Sell
141,286
-44,849
-24% -$530K ﹤0.01% 843
2024
Q3
$2.22M Buy
186,135
+158,179
+566% +$1.37M 0.01% 715
2024
Q2
$159K Buy
27,956
+22,399
+403% +$123K ﹤0.01% 1468
2024
Q1
$28K Buy
+5,557
New +$27.2K ﹤0.01% 1443
2021
Q3
– Sell
-12,461
Closed -$220K – 1741
2021
Q2
$220K Buy
+12,461
New +$201K ﹤0.01% 1408

Other funds holding BVS

Acadian Asset Management's BVS Position: Q2 2026 in Review

Acadian Asset Management increased its Bioventus (BVS) stake by 1.2% in Q2 2026, buying an estimated $37.1K and bringing the position to 336,998 shares worth $3.18M. The position accounts for ﹤0.01% of the portfolio, ranked #931.

Acadian Asset Management first reported a position in BVS in Q2 2021 and has held it in 10 quarters since. 156 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Acadian Asset Management held 336,998 shares of Bioventus worth $3.18M as of Q2 2026.
  • Acadian Asset Management bought 3,883 Bioventus shares in Q2 2026, an estimated $37.1K.
  • Bioventus made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #931 holding.
  • Acadian Asset Management first reported a position in Bioventus in Q2 2021 and has held it in 10 quarters since.
  • 156 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.